Evaluating the Effects of Aluminum-Containing and Non-Aluminum Containing Deodorants on Axillary Skin Toxicity During Radiation Therapy for Breast Cancer: A 3-Armed Randomized Controlled Trial

Published:September 04, 2014DOI:


      Deodorant use during radiation therapy for breast cancer has been controversial as there are concerns deodorant use may exacerbate axillary skin toxicity. The present study prospectively determined the use of both aluminum-containing and non aluminum containing deodorants on axillary skin toxicity during conventionally fractionated postoperative radiation therapy for breast cancer.

      Methods and Materials

      This 3-arm randomized controlled study was conducted at a single center, tertiary cancer hospital between March 2011 and April 2013. Participants were randomized to 1 of 2 experimental groups (aluminum-containing deodorant and soap or non–aluminum containing deodorant and soap) or a control group (soap). A total of 333 participants were randomized. Generalized estimating equations were used to estimate and compare the odds of experiencing high levels of sweating and skin toxicity in each of the deodorant groups to the odds in the control group. The study evaluated a range of endpoints including objective measurements of axilla sweating, skin toxicity, pain, itch and burning. Quality of life was assessed with a validated questionnaire.


      Radiation characteristics were similar across all groups. Patients in the deodorant groups did not report significantly different ratings for axillary pain, itch, or burning compared with the control group. Patients in the aluminum-containing deodorant group experienced significantly less sweating than the control; the odds of their sweating being barely tolerable and frequently or always interfering with their daily activities was decreased by 85% (odds ratio, 0.15; 95% confidence interval, 0.03-0.91).


      We found no evidence that the use of either aluminum-containing or non–aluminum containing deodorant adversely effects axillary skin reaction during conventionally fractionated radiation therapy for breast cancer. Our analysis also suggests patients in the aluminum-containing deodorant arm had significantly less sweating without increased symptoms of axillary radiation skin toxicity. These results add to the evidence that the prescription of deodorants during radiation therapy for breast cancer is now questionable.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Théberge V.
        • Harel F.
        • Dagnault A.
        Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: A prospective randomized noninferiority trial.
        Int J Radiat Oncol Biol Phys. 2009; 75: 1048-1052
        • Cumming J.
        • Routsis D.
        Are improvements needed in the management of severe acute skin reactions following completion of breast radiotherapy? A discussion of some possible service options.
        J Radiother Pract. 2009; 8: 11-16
        • McQuestion M.
        Evidence-based skin care management in radiation therapy.
        Semin Oncol Nurs. 2006; 22: 163-173
        • Roy I.
        • Fortin A.
        • Larochelle M.
        The impact of skin washing with water and soap during breast irradiation: A randomized study.
        Radiother Oncol. 2001; 58: 333-339
        • Watson L.
        • Gies D.
        • Thompson E.
        • et al.
        Randomized control trial: Evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of stage 0, I, and II breast cancer.
        Int J Radiat Oncol Biol Phys. 2012; 83: e29-e34
        • Burch S.
        • Parker S.
        • Vann A.
        • et al.
        Measurement of 6-Mv X-ray surface dose when topical agents are applied prior to external beam irradiation.
        Int J Radiat Oncol Biol Phys. 1997; 38: 447-451
        • Gee A.
        • Moffitt D.
        • Churn M.
        • et al.
        A randomized controlled trial to test a non-metallic deodorant used during a course of radiotherapy.
        J Radiother Pract. 2000; 1: 205-212
        • Graham P.
        • Graham J.
        Use of deodorants during adjuvant breast radiotherapy: A survey of compliance with standard advice, impact on patients and a literature review on safety.
        J Med Imaging Radiat Oncol. 2009; 53: 569-673
        • Aistars J.
        The validity of skin care protocols followed by women with breast cancer receiving external radiation.
        Clin J Oncol Nurs. 2006; 10: 487-492
        • Bennett C.
        An investigation into the use of a non-metallic deodorant during radiotherapy treatment: A randomized controlled trial.
        J Radiother Pract. 2009; 8: 3-9
        • Tortorelli G.
        • Di Murro L.
        • Barbarino R.
        • et al.
        Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities.
        BMC Cancer. 2013; 13: 230
        • Deantonio L.
        • Gambaro G.
        • Beldi D.
        • et al.
        Hypofractionated radiotherapy after conservative surgery for breast cancer: Analysis of acute and late toxicity.
        Radiat Oncol. 2010; 5: 112
        • Osako T.
        • Oguchi M.
        • Kumada M.
        • et al.
        Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
        Jpn J Clin Oncol. 2008; 38: 334-338
        • Hardefeldt P.
        • Edirimanne S.
        • Eslick G.
        Deodorant use and the risk of skin toxicity in patients undergoing radiation therapy for breast cancer: A meta-analysis.
        Radiat Oncol. 2012; 105: 378-379
        • Cox J.
        • Stetz J.
        • Pajak T.
        Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).
        Int J Radiat Oncol Biol Phys. 1995; 31: 1341-1346
        • Glean E.
        • Edwards S.
        • Faithfull S.
        • et al.
        Intervention for acute radiotherapy induced skin reactions in cancer patients: The development of a clinical guideline recommended for use by the College of Radiographers.
        J Radiother Pract. 2000; 2: 75-84
        • Strutton D.
        • Kowalski J.
        • Glaser D.
        • et al.
        U.S. prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey.
        J Am Acad Dermatol. 2004; 51: 241-248
        • Aaronson N.
        • Ahmedzai S.
        • Bergman B.
        • et al.
        The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology.
        J Natl Cancer Inst. 1993; 85: 365-376
        • Kaasa S.
        • Bjordal K.
        • Aaronson N.
        • et al.
        The EORTC core quality of life questionnaire (QLQ-C30): Validity and reliability when analysed with patients treated with palliative radiotherapy.
        Eur J Cancer. 1995; 31A: 2260-2263
        • Fisher J.
        • Scott C.
        • Stevens R.
        • et al.
        Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
        Int J Radiat Oncol Biol Phys. 2000; 48: 1307-1310
        • Wittes J.
        Sample size calculations for randomized controlled trials.
        Epidemiol Rev. 2002; 24: 39-53
        • Sharp L.
        • Johansson H.
        • Hatschek T.
        • et al.
        Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer.
        Breast. 2013; 22: 634-638


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.